Replies to post #70667 on Biotech Values

[Tina]

interesting

[mouton29]

<<Latisse will easily outsell Lumigan, which does about $500M annually...>>

I know a number of female glaucoma patients who have switched from Lumigan to alternatives because of darkening of the eyelids. If this is a concern where your vision is involved, I would guess it would be more of a concern where the drug is being taken for purely cosmetic reasons. This side effect is well-known -- google
"+lumigan +"raccoon eyes"".

[rkrw]

Do you think this will ever move to OTC?

[genisi]

2009 sales guidance for Latisse: 30-$50M.

[DewDiligence]

Could AGN have found a better spokesperson for Latisse than Christina Hendricks? I doubt it.

http://finance.yahoo.com/news/Christina-Hendricks-Kicks-Off-prnews-1769682084.html?x=0&.v=1